Free Trial
OTCMKTS:BETRF

BetterLife Pharma (BETRF) Stock Price, News & Analysis

BetterLife Pharma logo
$0.13 -0.01 (-10.56%)
As of 11:33 AM Eastern

About BetterLife Pharma Stock (OTCMKTS:BETRF)

Advanced

Key Stats

Today's Range
$0.13
▼
$0.15
50-Day Range
$0.13
▼
$0.28
52-Week Range
$0.03
▼
$0.33
Volume
67,005 shs
Average Volume
94,744 shs
Market Capitalization
$21.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BetterLife Pharma Inc. is a Canadian biotechnology company developing drug candidates for mental health and neurological conditions, with a focus on psychedelic-related compounds.

Its pipeline includes BETR-001, a non-hallucinogenic LSD derivative being investigated for depression and other neuropsychiatric disorders, and BETR-002, an ibogaine-derived candidate being developed for substance use disorders.

BetterLife’s work is focused on research and development; these candidates are investigational and are not approved treatments. The company is based in Canada.

AI Generated. May Contain Errors.

BetterLife Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
5th Percentile Overall Score

BETRF MarketRank™: 
0.27140013271 of 5 stars

BetterLife Pharma scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for BetterLife Pharma.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of BetterLife Pharma is -14.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of BetterLife Pharma is -14.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.06% of the float of BetterLife Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    BetterLife Pharma has a short interest ratio ("days to cover") of 0.31, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in BetterLife Pharma has recently decreased by 3.53%, indicating that investor sentiment is improving.
  • Dividend Yield

    BetterLife Pharma does not currently pay a dividend.

  • Dividend Growth

    BetterLife Pharma does not have a long track record of dividend growth.

  • MarketBeat Follows

    1 people have added BetterLife Pharma to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, BetterLife Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    34.77% of the stock of BetterLife Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    0.01% of the stock of BetterLife Pharma is held by institutions.

  • Read more about BetterLife Pharma's insider trading history.
Receive BETRF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BetterLife Pharma and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BETRF Stock News Headlines

This Could Be the Biggest Monetary Shift in 50 Years
The U.S. government still values its gold reserves at $42 an ounce, a price set by Congress in 1973. Gold trades above $4,000 today. That gap means Washington's books show about $11 billion in gold that is actually worth more than $1 trillion. A bill in Congress would require repricing those reserves at market value. More than 60 million Americans qualify to move part of their savings into physical gold, tax-free and penalty-free, according to the 2026 Gold and Silver Guide.tc pixel
Accionistas de BetterLife Pharma Inc
See More Headlines

BETRF Stock Analysis - Frequently Asked Questions

BetterLife Pharma's stock was trading at $0.0323 at the start of the year. Since then, BETRF shares have increased by 336.8% and is now trading at $0.1411.

BetterLife Pharma Inc. (OTCMKTS:BETRF) announced its quarterly earnings results on Tuesday, September, 29th. The company reported ($0.01) EPS for the quarter.

Shares of BETRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
9/29/2026
Today
11/16/2026
Fiscal Year End
1/31/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:BETRF
CIK
1464165
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.07 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-499.72%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.21
Quick Ratio
0.21

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.03) per share
Price / Book
-4.21

Miscellaneous

Outstanding Shares
170,120,000
Free Float
110,966,000
Market Cap
$21.47 million
Optionable
Not Optionable
Beta
0.26
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (OTCMKTS:BETRF) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners